Available evidence from human clinical studies suggests that marijuana (limited evidence) and prescription cannabinoid-based medicines (dronabinol) may increase appetite and caloric intake, and promote weight gain in patients with HIV/AIDS. Has the use of cannabinoid-based medicines in cancer or anorexia nervosa been evaluated, too? |
|
Evidence from observational studies and clinical studies suggests that marijuana (limited evidence) and prescription cannabinoids (e.g. dronabinol, nabilone, or nabiximols) may be useful in alleviating one or several co-occurring symptoms often experienced by patients in the palliative care setting. What are some of these palliative care setting symptoms? |
|
Some cannabinoid-based drugs have been approved by national drug administrations. For example, Epidiolex (a CBD product) has been approved by the US FDA for the treatment of rare pediatric seizure disorders (Lennox-Gastaut syndrome, Dravet syndrome and tuberous sclerosis complex). Other than seizure disorders, what are the therapeutic indications for cannabinoid-based medicines that have been approved by a national drug administration? |
Only have a minute but want to Learn something every day®? Sign up to receive The Answer of the Day, bringing featured content from our course library right to your inbox each day.
TheAnswerPage Announces Our New CBD in Clinical Care Course
TheAnswerPage was launched in 1998 to provide daily education to healthcare providers in training and in practice.
Jeffrey Sherwood Block, M.D. . is a Board-certified physician anesthesiologist and adjunct Professor at the University of Miami Miller School of Medicine. Additionally, he is a highly awarded horticulturist and certified Master Gardener educator with the University of Florida’s UF/IFAS Extension Program. Dr. Block’s textbook chapter “Endocannabinoid Receptors and Medical Cannabis” (Advanced Therapeutics in Pain Medicine – CRC Press 2020) is a sentinel work on integrated pain management. Block served as the Florida Medical Association’s “Designated Expert on Botanical Medicines” authoring mandated physician education; and in 2014 was appointed by Florida’s Surgeon General to determine the rules for Florida’s first cannabis law. His consultancy’s demonstrated insight and responsible leadership are valued by both allied professionals and new industries seeking knowledge of future uses for Cannabinoid medicines.